Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125192501 | 12519250 | 1 | I | 20131031 | 20160112 | 20160701 | 20160701 | PER | GB-MHRA-EYC 00133372 | GB-LUPIN PHARMACEUTICALS INC.-E2B_00004782 | LUPIN | 63.00 | YR | F | Y | 55.00000 | KG | 20160624 | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125192501 | 12519250 | 1 | PS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | Y | U | UNKNOWN | 78103 | 80 | MG | ||||||
125192501 | 12519250 | 2 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | 0 | |||||||||||
125192501 | 12519250 | 3 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125192501 | 12519250 | 1 | Myocardial infarction |
125192501 | 12519250 | 2 | Product used for unknown indication |
125192501 | 12519250 | 3 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125192501 | 12519250 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125192501 | 12519250 | Muscular weakness |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125192501 | 12519250 | 1 | 20071130 | 20130331 | 0 |